Clinical Trial Update: Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Carboplatin, Abraxane, and Avastin as neoadjuvant therapy for HER2-negative breast cancer. Completed with results posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: William Sikov MD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-08